| __timestamp | ACADIA Pharmaceuticals Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 120000 | 751040000 |
| Thursday, January 1, 2015 | 61000 | 889895000 |
| Friday, January 1, 2016 | 17331000 | 1116854000 |
| Sunday, January 1, 2017 | 124901000 | 1313646000 |
| Monday, January 1, 2018 | 223807000 | 1491212000 |
| Tuesday, January 1, 2019 | 339076000 | 1704048000 |
| Wednesday, January 1, 2020 | 441755000 | 1860455000 |
| Friday, January 1, 2021 | 484145000 | 1846275000 |
| Saturday, January 1, 2022 | 517235000 | 2096039000 |
| Sunday, January 1, 2023 | 726437000 | 2419226000 |
| Monday, January 1, 2024 | 2853915000 |
Unlocking the unknown
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. have shown contrasting revenue trajectories. BioMarin, a leader in the field, has consistently increased its revenue, achieving a remarkable 222% growth from 2014 to 2023. In 2023, BioMarin's revenue peaked at approximately $2.42 billion, showcasing its robust market presence.
On the other hand, ACADIA Pharmaceuticals has experienced a more volatile journey. Starting with a modest revenue in 2014, ACADIA has seen a staggering increase of over 6000% by 2023, reaching around $726 million. This dramatic rise highlights ACADIA's potential and growing influence in the biotech sector. Despite the differences in scale, both companies exemplify the innovative spirit driving the biotechnology industry forward.
Novartis AG vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Bristol-Myers Squibb Company vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: Biogen Inc. vs BioMarin Pharmaceutical Inc.
Breaking Down Revenue Trends: BeiGene, Ltd. vs ACADIA Pharmaceuticals Inc.
Breaking Down Revenue Trends: Genmab A/S vs ACADIA Pharmaceuticals Inc.
Who Generates More Revenue? Bio-Techne Corporation or BioMarin Pharmaceutical Inc.
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Veracyte, Inc.?
BioMarin Pharmaceutical Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc. Performance Compared